Enhancing Muscle Membrane Repair by Gene Delivery of MG53 Ameliorates Muscular Dystrophy and Heart Failure in δ-Sarcoglycan-deficient Hamsters

Wang, 2009, Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice, J Orthop Res, 27, 421, 10.1002/jor.20781 Wang, 2000, Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model, Proc Natl Acad Sci USA, 97, 13714, 10.1073/pnas.240335297 Zhu, 2005, Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer, Circulation, 112, 2650, 10.1161/CIRCULATIONAHA.105.565598 Goyenvalle, 2004, Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping, Science, 306, 1796, 10.1126/science.1104297 Lostal, 2010, Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer, Hum Mol Genet, 19, 1897, 10.1093/hmg/ddq065 Goonasekera, 2011, Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle, J Clin Invest, 121, 1044, 10.1172/JCI43844 Millay, 2009, Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism, Proc Natl Acad Sci USA, 106, 19023, 10.1073/pnas.0906591106 Bansal, 2003, Defective membrane repair in dysferlin-deficient muscular dystrophy, Nature, 423, 168, 10.1038/nature01573 Ellis, 2003, Cell biology: Patches for wounded muscle, Nature, 423, 129, 131, 10.1038/423129a Han, 2007, Dysferlin and muscle membrane repair, Curr Opin Cell Biol, 19, 409, 10.1016/j.ceb.2007.07.001 Cai, 2009, Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin, J Biol Chem, 284, 15894, 10.1074/jbc.M109.009589 Cai, 2009, MG53 nucleates assembly of cell membrane repair machinery, Nat Cell Biol, 11, 56, 10.1038/ncb1812 Cai, 2009, MG53 regulates membrane budding and exocytosis in muscle cells, J Biol Chem, 284, 3314, 10.1074/jbc.M808866200 Hoshijima, 2011, Delta-sarcoglycan gene therapy halts progression of cardiac dysfunction, improves respiratory failure, and prolongs life in myopathic hamsters, Circ Heart Fail, 4, 89, 10.1161/CIRCHEARTFAILURE.110.957258 Wang, 2005, Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart, Nat Biotechnol, 23, 321, 10.1038/nbt1073 Salva, 2007, Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle, Mol Ther, 15, 320, 10.1038/sj.mt.6300027 Inagaki, 2006, Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8, Mol Ther, 14, 45, 10.1016/j.ymthe.2006.03.014 Wang, 2006, Widespread and stable pancreatic gene transfer by adeno-associated virus vectors via different routes, Diabetes, 55, 875, 10.2337/diabetes.55.04.06.db05-0927 Wang, 2008, Construction and analysis of compact muscle-specific promoters for AAV vectors, Gene Ther, 15, 1489, 10.1038/gt.2008.104 Qiao, 2011, Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver, Gene Ther, 18, 403, 10.1038/gt.2010.157 Piccolo, 2000, Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb–girdle muscular dystrophies, Ann Neurol, 48, 902, 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.0.CO;2-Z Feron, 2009, PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle, Am J Pathol, 174, 1459, 10.2353/ajpath.2009.080460 Peter, 2006, Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway, Exp Cell Res, 312, 2580, 10.1016/j.yexcr.2006.04.024 Cao, 2010, MG53 constitutes a primary determinant of cardiac ischemic preconditioning, Circulation, 121, 2565, 10.1161/CIRCULATIONAHA.110.954628 Girgenrath, 2004, Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy, J Clin Invest, 114, 1635, 10.1172/JCI22928 Hikoso, 2007, Progression of heart failure was suppressed by inhibition of apoptosis signal-regulating kinase 1 via transcoronary gene transfer, J Am Coll Cardiol, 50, 453, 10.1016/j.jacc.2007.03.053 Hoffman, 2007, Skipping toward personalized molecular medicine, N Engl J Med, 357, 2719, 10.1056/NEJMe0707795 Bellinger, 2009, Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle, Nat Med, 15, 325, 10.1038/nm.1916 Qiao, 2008, Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice, Hum Gene Ther, 19, 241, 10.1089/hum.2007.159 Rooney, 2009, Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy, Proc Natl Acad Sci USA, 106, 7991, 10.1073/pnas.0811599106 Millay, 2008, Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy, Nat Med, 14, 442, 10.1038/nm1736 Yang, 2009, A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection, Proc Natl Acad Sci USA, 106, 3946, 10.1073/pnas.0813207106 Pulicherla, 2011, Engineering Liver-detargeted AAV9 Vectors for Cardiac and Musculoskeletal Gene Transfer, Mol Ther, 19, 1070, 10.1038/mt.2011.22 Han, 2007, Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury, J Clin Invest, 117, 1805, 10.1172/JCI30848 Hernández-Deviez, 2008, Caveolin regulates endocytosis of the muscle repair protein, dysferlin, J Biol Chem, 283, 6476, 10.1074/jbc.M708776200 Wang, 2010, Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair, Circ Res, 107, 76, 10.1161/CIRCRESAHA.109.215822 Xiao, 1998, Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus, J Virol, 72, 2224, 10.1128/JVI.72.3.2224-2232.1998 Ayuso, 2010, High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency, Gene Ther, 17, 503, 10.1038/gt.2009.157